Related Experiment Video

Updated: Jul 5, 2026

Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells
09:27

Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells

Published on: April 2, 2021

Caspofungin for treatment of invasive aspergillus infections

W J Heinz1, H Einsele

  • 1Medizinische Klinik and Poliklinik II, University Hospital, Würzburg, Germany. heinz_w@klinikum.uni-wuerzburg.de

Mycoses
|May 28, 2008
PubMed

Insights

Invasive aspergillosis is a growing threat, especially for immunocompromised patients. Caspofungin offers a potential alternative or partner in antifungal therapy due to its safety and efficacy in clinical trials.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Invasive aspergillosis incidence is rising, posing a significant threat to immunocompromised individuals, particularly hematological patients and solid organ transplant recipients.
  • While voriconazole is standard therapy and new agents exist, optimal treatment strategies for invasive aspergillosis remain under investigation.
  • Significant advancements in antifungal therapy are still required to combat invasive aspergillus infections effectively.

Purpose of the Study:

  • To review the current knowledge on using caspofungin for invasive aspergillosis treatment.
  • To discuss factors influencing the selection of antifungal agents in aspergillosis therapy.
  • To evaluate caspofungin's role as a therapeutic option in managing invasive aspergillosis.

Main Methods:

  • Literature review of clinical trials and studies involving caspofungin in invasive aspergillosis.
  • Analysis of treatment guidelines and expert opinions on antifungal choices.
  • Evaluation of caspofungin's efficacy, safety profile, and mechanism of action compared to other antifungals.

Main Results:

  • Caspofungin, an echinocandin, has demonstrated a broad range of clinical evaluations and a favorable safety profile.
  • Its alternative target mechanism makes it a potentially suitable partner in combination antifungal therapy for aspergillosis.
  • Clinical data supports caspofungin's utility in various patient populations and clinical scenarios.

Conclusions:

  • Caspofungin presents a valuable option in the anti-aspergillus therapeutic armamentarium.
  • Its favorable safety profile and alternative mechanism warrant consideration in treatment strategies.
  • Further research and discussion are needed to optimize the choice, duration, and sequence of antifungal agents for invasive aspergillosis.

More Related Videos

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...